Hematogenix’s proprietary Multiple Myeloma MRD (MM MRD) assay measured the primary efficacy endpoint cited in the FDA-approval of ZENBEXUS (iberdomide), reinforcing Hematogenix’s role as a specialized global leader in registrational oncology trials.
A research team led by Professor Ji Won Um of the Center for Synapse Diversity and Specificity, Department of Brain Sciences, DGIST, in collaboration with a team led by Professor Alice Ting at Stanford University, has developed LATeNT, a novel optical control platform that uses light to block signal transmission between neurons and subsequently restore normal signaling. The work is published in the journal Nature Methods.
Melbourne researchers have made a gene therapy breakthrough that could restore heart function in children with genetic heart disease, sparing them the need for transplants.
Every RNA virus—from stomach bugs and influenza to measles and the common cold—has its own story to tell, with a unique combination of symptoms, transmission rates, duration and chemical blueprint.
A research team has developed a wearable patch that simultaneously promotes wound closure and tissue regeneration using room light or sunlight, without batteries or an external electrical power source. The work has been published online in Advanced Materials.
Madison researchers have developed an implantable, battery-free pacemaker that’s charged by a patient’s heartbeat. The device has the potential to last an entire lifetime, reducing the risks and costs associated with replacing devices when their batteries fail.
US drugmakers Merck and Moderna said Wednesday a personalized cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a “breakthrough.”
Cancer spreading beyond the primary tumor—a process known as metastasis—is responsible for at least two-thirds of cancer deaths. Drugs targeting metastatic progression have largely failed, in part because of the lack of predictive models that would help identify the underlying mechanisms of metastasis.
A compound produced in the body after eating pomegranates improves heart function by up to 80% in a type of heart failure with limited treatment options.
With more than 7 million Americans living with Alzheimer’s dementia—a number projected to reach nearly 13 million by 2050—new Emory University research suggests that higher vitamin D supplement intake may be associated with better cognitive function in adults at elevated risk of dementia.